174 related articles for article (PubMed ID: 6590470)
1. In vitro approach to 7-hydroxymethotrexate interaction on methotrexate metabolism as tool of pharmacokinetic study.
Fabre G; Cano JP; Catalin J; Just S
Int J Clin Pharmacol Res; 1983; 3(6):475-84. PubMed ID: 6590470
[TBL] [Abstract][Full Text] [Related]
2. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
Fabre G; Goldman ID
Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
[TBL] [Abstract][Full Text] [Related]
3. In vitro formation of polyglutamyl derivatives of methotrexate and 7-hydroxymethotrexate in human lymphoblastic leukemia cells.
Fabre G; Matherly LH; Favre R; Catalin J; Cano JP
Cancer Res; 1983 Oct; 43(10):4648-52. PubMed ID: 6192907
[TBL] [Abstract][Full Text] [Related]
4. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
5. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
6. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
Jolivet J; Cole DE; Holcenberg JS; Poplack DG
Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
[TBL] [Abstract][Full Text] [Related]
7. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
[TBL] [Abstract][Full Text] [Related]
8. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
9. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro.
Fabre G; Matherly LH; Fabre I; Cano JP; Goldman ID
Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419
[TBL] [Abstract][Full Text] [Related]
10. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
Fabre I; Fabre G; Goldman ID
Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
[TBL] [Abstract][Full Text] [Related]
11. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
Lingg RM; Hempel G; Rots MG; Van Zantwijk CH; Boos J; Kaspers GJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):322-7. PubMed ID: 15868145
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the formation and membrane transport of 7-hydroxymethotrexate in freshly isolated rabbit hepatocytes.
Fabre G; Fabre I; Gewirtz DA; Goldman ID
Cancer Res; 1985 Mar; 45(3):1086-91. PubMed ID: 2578871
[TBL] [Abstract][Full Text] [Related]
14. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
15. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic analysis of MTX, 7-OH-MTX and MTX derivatives: application to intracellular metabolism in tumor cells (HT 29).
Durand R; Fabre G; Cano JP; Catalin J; Ahmed OA; Just S
J Appl Toxicol; 1983 Aug; 3(4):189-95. PubMed ID: 6196390
[TBL] [Abstract][Full Text] [Related]
18. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
19. Interactions between 7-hydroxymethotrexate and folinic acid in RAJI cells, in vitro.
Payet B; Fabre I; Fabre G; Cano JP
Cancer Lett; 1988 Feb; 39(1):45-58. PubMed ID: 3257895
[TBL] [Abstract][Full Text] [Related]
20. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
Chen ML; McGuire WP; Lad TE; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]